ClinicalTrials.gg
RecruitingNCT06533904Updated Nov 12, 2026

Percutaneous Cryoablation of Intercostal Nerves for the Treatment of Rib Fractures

An interventional study of Percutaneous Cryoablation of Intercostal Nerves and Multi-modal pain regimen in Trauma, Rib Fractures and Chest Wall Disorder, sponsored by Loma Linda University. Recruiting at 1 site in United States. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-12.

Primary conditionRib FracturesRegistry: Wounds and InjuriesReclassifiedWhy we changed it
Registry
Wounds and Injuries — the first condition term the registry derived for this study.
ClinicalTrials.gg
Rib Fractures
Why
  1. The study's listed conditions name Rib Fractures, a narrower term within Wounds and Injuries.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Loma Linda University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jun 2024; still recruiting 2 years 5 months later.
Updated Nov 12, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 48 studies in Rib Fractures with a site in United States — 9 open to participants now, 10 under way, none of them phase 3. Rib Fractures · United States.

Planned enrollment
25th of 41
30 · median 36
Started
2024
with 3 others
No phase
18 of 48
4 open now
Registered
44th of 48
by date

Among the 48 studies in Rib Fractures with a site in United States, this one is the 25th largest by planned enrollment of the 41 interventional ones that give a count, is one of 4 that started in 2024, is one of 18 with no phase, and was the 44th registered.

Rib Fractures

126 studies on the registry are indexed under Rib Fractures; 28 are open to participants now.

Browse Rib Fractures studies →

Open to participants now

9 of the 48 studies in Rib Fractures with a site in United States are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 14 Rib Fractures studies recruiting now, 9 (64%) set no upper age limit and 1 (7%) stops at 75 or younger; none take children under 18; 3 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 48 studies in Rib Fractures with a site in United States, or all of them as a file.
02

Study summary

The goal of this double blinded randomized control trial is to learn if percutaneous cryoablation of traumatic rib fractures improves outcomes. The main questions it aims to answer are:

Does percutaneous cryoablation improve short and long term pain scores? Does percutaneous cryoablation improve short and long term respiratory mechanics? Does percutaneous cryoablation improve long term quality of life? Does percutaneous cryoablation decrease delirium?

Researchers will compare cryoablation to standard multimodal pain therapy to see if this impacts respiratory recovery.

Participants will undergo randomization, percutaneous cryoablative procedure, and participate in tests at pre-determined intervals to evaluate their pulmonary recovery.

03

Conditions studied

  • Trauma
  • Rib Fractures
  • Chest Wall Disorder
  • Respiratory Insufficiency
  • Pain, Chest
  • Rib Trauma
  • Rib Fracture Multiple
  • Respiratory Failure
  • Respiratory Distress Syndrome

Keywords

  • Trauma
  • Respiratory Failure
  • Respiratory Distress
  • Respiratory Insufficiency
  • Rib Fractures
  • Chest Wall Trauma
  • Percutaneous Cryoablation
  • Multimodal Pain Therapy
  • Multimodal Pain Regimen
04

In context

Rib Fractures Reclassified

126 studies on the registry are indexed under Rib Fractures; 28 are open to participants now.

This study's planned enrollment of 30 is below the median of 60 across 92 interventional studies indexed under Rib Fractures.

Browse Rib Fractures studies →

Lead sponsor

Loma Linda University is the lead sponsor of 306 studies on the registry; 46 are open to participants now.

Of its 29 completed or terminated interventional studies of FDA-regulated products, 23 (79%) have results posted.

Compared within Rib Fractures, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Wounds and Injuries. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • > 18 years old
  • > 2 rib fractures
  • Verbal Pain score > 5
  • Incentive Spirometry \< 60% of predicted

Exclusion criteria

Exclusion Criteria:

  • Isolated Fractures of Ribs 1-3 and/or 10-12
  • Posterior Rib Fracture \< 4 cm from costovertebral joint
  • Sternal, Clavicle, Scapula Fracture
  • Thoracic Spinal Fracture of any type
  • Open Abdominothoracic Surgery
  • Unstable Spine
  • Extensive Subcutaneous Emphysema
  • > 35
  • Plan for Rib Plating
  • Chronic Opioid Use
  • Prior to study enrollment: Intubated, Traumatic Brain Injury, Dementia, Cognitive Impairment, Encephalopathy
  • Coagulopathy, Shock at time of ablation
  • Inability to participate in activities of daily living prior to injury
  • Home O2 use prior to trauma
  • Inhalation Injury
  • Rib Fractures due to cardiopulmonary resuscitation
  • \< 6 months
  • > 48 hours from injury
  • Pregnant, Incarcerated
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
Double (Participant, Investigator)
Enrollment
30 participants (estimated)

Study arms

  • Placebo comparator
    Standard multi-modal pain regimen alone

    Other: Multi-modal pain regimen

  • Experimental
    Standard multi-modal pain regimen with percutaneous cryoablation

    Procedure: Percutaneous Cryoablation of Intercostal Nerves · Other: Multi-modal pain regimen

Interventions

  • ProcedurePercutaneous Cryoablation of Intercostal Nerves

    Percutaneous Cryoablation of Intercostal Nerves

  • OtherMulti-modal pain regimen

    Standard rib fracture protocol including cyclooxygenase inhibitors, anti-neuropathic, muscle relaxers, short term anesthesia interventions (percutaneous block, epidural)

07

What researchers measure

Primary outcomes

  1. Pain Score: Numeric Pain Scale

    Short and Long Term Pain Scores. Range from 0 to 10 where 0 is no pain and 10 is most severe and worse outcome.

    Time frame: Through study completion, up to 1 year

  2. Rate of abnormal respiratory mechanics: Incentive Spirometry

    Time frame: Through study completion, up to 1 year

  3. Rate of abnormal respiratory mechanics: Pulmonary Function Tests

    Short and Long Term Respiratory Mechanics. Pulmonary Function Tests will specifically measure Forced Expiratory Volume in 1 second (FEV1) and Forced Vital Capacity (FVC)

    Time frame: Through study completion, up to 1 year

  4. Rate of delirium: Confusion Assessment Method (CAM) Score

    The score ranges from 0 to 19. Where higher scores indicate more severe delirium and low scores indicate less severe or no delirium

    Time frame: Through study completion, up to 1 year

  5. Quality of Life on Survey

    Long Term Quality of Life

    Time frame: Through study completion, up to 1 year

Secondary outcomes

  1. Rate of Pneumonia

    Time frame: Through study completion, up to 1 year

  2. Rate of need for Intubation/Mechanical Ventilation

    Time frame: Through study completion, up to 1 year

  3. Rate of need for tracheostomy

    Time frame: Through study completion, up to 1 year

  4. Number of Ventilatory Days

    Time frame: Through study completion, up to 1 year

  5. ICU Length of Stay

    Time frame: Through study completion, up to 1 year

  6. Hospital Length of Stay

    Time frame: Through study completion, up to 1 year

  7. Acute Respiratory Distress Syndrome

    Time frame: Through study completion, up to 1 year

  8. Rate of Mortality

    Time frame: Through study completion, up to 1 year

  9. Rate of Pleural Space Complications

    Hemothorax, Delayed hemothorax, Pneumothorax, Empyema, Hydrothorax, Rate of tube thoracostomy

    Time frame: Through study completion, up to 1 year

08

Study locations

1 of 1 sites recruiting
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2024 (actual). Primary completion is estimated for Jul 2028, 49 months after the start.

Of 41 non-industry interventional studies with no phase under Rib Fractures, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 37. This study's planned 49 months is above that.

Counting every sponsor, half of 41 studies reached it within 23 months; a quarter within 15 and three quarters within 37.

Start moved once since we started tracking on Sep 25, 2026: Sep 2026 → Jun 2024, on Nov 12, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 30, 2024
First posted
Aug 1, 2024
StartActual
Jun 2, 2024was Sep 2026
Primary completionEst.
Jul 2028
CompletionEst.
Jul 2028
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 12, 2026
Sites
Loma Linda University Health is now Recruiting
Nov 12, 2026
Start date
Sep 2026→Jun 2, 2024 (actual)
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Not yet recruiting→Recruiting
    Loma Linda University Health is now Recruiting
    Start date Sep 2026→Jun 2, 2024 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06533904
Responsible party
Sponsor
First posted
Aug 1, 2024
Start date
Jun 2, 2024
Primary completion
Jul 2028 (estimated)
Completion
Jul 2028 (estimated)
Last update
Nov 12, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion